NeuroSense Therapeutics stock price
뉴로센스 테라퓨틱스NASDAQ:NRSN · Nasdaq · Healthcare$3.94-2.84%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →NeuroSense Therapeutics last closed at $3.94 (-2.84%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -0.5×. Its overall grade ranks 473 of 739 stocks in Healthcare.
About this company
NeuroSense Therapeutics last closed at $3.94 (-2.84%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall C+ · 473/739
Valuation grade B
Related stocks
- BiogenCompetitor
ALS 및 신경퇴행성 질환 치료제 개발에서 경쟁 관계
- Amylyx PharmaceuticalsCompetitor
ALS 치료제 개발·상용화 영역에서 경쟁
- Amyotrophic Lateral Sclerosis AssociationRelated theme
ALS 치료제 개발의 핵심 질환 테마
About NeuroSense Therapeutics
- What technical signals does NeuroSense Therapeutics (NRSN) have?
- NeuroSense Therapeutics current technical signals: no active technical signal.
- Is NeuroSense Therapeutics a cup-and-handle pattern?
- No. NeuroSense Therapeutics has no valid Cup signal right now.
- What published figures are available for NeuroSense Therapeutics?
- Market cap: $117.02M. Trailing 12 months PER: -0.5×. Latest quarter PBR: -3.22×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about NeuroSense Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).
Quantus Signal · live data · not investment advice · Privacy Policy